Astellas Pharma, Inc. (ALPMY)
15.04
0.00 (0.00%)
USD |
OTCM |
Aug 24, 16:00
Astellas Pharma Total Liabilities (Quarterly) : 10.76B for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 10.76B |
| March 31, 2026 | 10.91B |
| December 31, 2025 | 11.73B |
| September 30, 2025 | 12.44B |
| June 30, 2025 | 12.84B |
| March 31, 2025 | 12.21B |
| December 31, 2024 | 12.46B |
| September 30, 2024 | 13.51B |
| June 30, 2024 | 12.80B |
| March 31, 2024 | 13.04B |
| December 31, 2023 | 13.23B |
| September 30, 2023 | 12.76B |
| June 30, 2023 | 8.438B |
| March 31, 2023 | 7.127B |
| December 31, 2022 | 7.151B |
| September 30, 2022 | 6.454B |
| June 30, 2022 | 6.940B |
| March 31, 2022 | 7.185B |
| December 31, 2021 | 7.728B |
| September 30, 2021 | 7.563B |
| June 30, 2021 | 7.808B |
| March 31, 2021 | 8.032B |
| December 31, 2020 | 8.991B |
| September 30, 2020 | 8.598B |
| June 30, 2020 | 8.800B |
| Date | Value |
|---|---|
| March 31, 2020 | 9.504B |
| December 31, 2019 | 6.187B |
| September 30, 2019 | 6.326B |
| June 30, 2019 | 6.287B |
| March 31, 2019 | 5.775B |
| December 31, 2018 | 5.798B |
| September 30, 2018 | 5.320B |
| June 30, 2018 | 5.332B |
| March 31, 2018 | 5.547B |
| December 31, 2017 | 5.033B |
| September 30, 2017 | 4.840B |
| June 30, 2017 | 5.176B |
| March 31, 2017 | 4.866B |
| December 31, 2016 | 4.548B |
| September 30, 2016 | 4.799B |
| June 30, 2016 | 4.904B |
| March 31, 2016 | 4.806B |
| December 31, 2015 | 3.868B |
| September 30, 2015 | 3.737B |
| June 30, 2015 | 3.646B |
| March 31, 2015 | 3.966B |
| December 31, 2014 | 3.984B |
| September 30, 2014 | 3.832B |
| June 30, 2014 | 3.814B |
| March 31, 2014 |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Daiichi Sankyo Co., Ltd. | 14.84B |
| Takeda Pharmaceutical Co., Ltd. | 49.87B |
| Ono Pharmaceutical Co., Ltd. | 1.302B |
| Eisai Co., Ltd. | 3.845B |
| Chugai Pharmaceutical Co., Ltd. | 2.598B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 22.72B |
| Shareholders Equity (Quarterly) | 11.95B |
| Debt to Equity Ratio | 0.3036 |
| Current Ratio | 1.203 |
| Net Debt Paydown Yield | 2.20% |